UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of treatment with sofosbuvir/velpatasvir in patients aged 6–18 years with chronic hepatitis C—Results of the PANDAA‐PED study

Liver international, 2023-09, Vol.43 (9), p.1871-1878

2023

Volltextzugriff (PDF)

Health‐related quality of life in patients aged 6–18 years with chronic hepatitis C treated with sofosbuvir/velpatasvir

Liver international, 2024-01, Vol.44 (1), p.93-102

2024

Volltextzugriff (PDF)

Correct Implementation of Screening Testing Toward Congenital Infections During Pregnancy Reduces the Risk of Abnormal Fetal Ultrasound

The Pediatric infectious disease journal, 2022-06, Vol.41 (6), p.e271-e272

2022

Volltextzugriff (PDF)

Liver Fibrosis Evaluated With Transient Elastography in 35 Children With Chronic Hepatitis C Virus Infection

The Pediatric infectious disease journal, 2021-02, Vol.40 (2), p.103-108

2021

Volltextzugriff (PDF)

Real-Life Experience with Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Virus Infection with Genotypes 1 and 4 in Children Aged 12 to 17 Years—Results of the POLAC Project

Journal of clinical medicine, 2021-09, Vol.10 (18), p.4176

2021

Volltextzugriff (PDF)

Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C

BMC infectious diseases, 2017-05, Vol.17 (1), p.361-361, Article 361

2017

Volltextzugriff (PDF)

Analysis of Preventable Risk Factors for Toxoplasma gondii Infection in Pregnant Women: Case-Control Study

Journal of clinical medicine, 2022-02, Vol.11 (4), p.1105

2022

Volltextzugriff (PDF)

THU-403 Liver fibrosis and steatosis in children after effective treatment of chronic hepatitis C using direct acting antivirals

Journal of hepatology, 2024-06, Vol.80, p.S825-S825

2024

Volltextzugriff (PDF)

THU-387 Safety and efficacy of two pangenotypic direct acting antivirals (sofosbuvir/velpatasvir and glecaprevir/pibrentasvir) for the treatment of hepatitis C in children

Journal of hepatology, 2024-06, Vol.80, p.S820-S821

2024

Volltextzugriff (PDF)

The Influence of Treatment With Sofosbuvir/Velpatasvir on Children’s Growth—Results of the PANDAA-PED Study

The Pediatric infectious disease journal, 2024-09

2024

Volltextzugriff (PDF)

Is liver biopsy still needed in children with chronic viral hepatitis?

World journal of gastroenterology : WJG, 2015-11, Vol.21 (42), p.12141-12149

Maria Pokorska-?piewak Barbara Kowalik-Miko?ajewska Ma?gorzata Aniszewska Magdalena Pluta Magdalena Marczyńska

2015

Volltextzugriff (PDF)

Testing for HIV increases the odds of correct fetal ultrasound result

Tropical medicine and infectious disease, 2022-09, Vol.7 (9), p.1-6

2022

Volltextzugriff (PDF)

Progress and Barriers Towards Elimination of Chronic Hepatitis C in Children

Klinische Pädiatrie, 2021-09, Vol.233 (5), p.211-215

2021

Volltextzugriff (PDF)

Health‐related quality of life in patients aged 6–18years with chronic hepatitis C treated with sofosbuvir/velpatasvir

Liver international, 2024-01, Vol.44 (1), p.93-102

2024

Volltextzugriff (PDF)

Liver steatosis in children with chronic hepatitis B and C: Prevalence, predictors, and impact on disease progression

Medicine (Baltimore), 2017-01, Vol.96 (3), p.e5832-e5832

2017

Volltextzugriff (PDF)

Efficacy and safety of treatment with sofosbuvir/velpatasvir in patients aged 6–18years with chronic hepatitis C—Results of the PANDAA‐PED study

Liver international, 2023-09, Vol.43 (9), p.1871-1878

2023

Volltextzugriff (PDF)

Pruritic, Bizarre Tracks- A Vacation Souvenir

Klinische Pädiatrie, 2018-03, Vol.230 (2), p.102-103

2018

Volltextzugriff (PDF)

The micro-elimination approach - a new way of tackling hepatitis C in paediatric population

Archives of medical science, 2021-06

2021

Volltextzugriff (PDF)

The influence of hepatitis B and C virus coinfection on liver histopathology in children

European journal of pediatrics, 2015-03, Vol.174 (3), p.345-353

2015

Volltextzugriff (PDF)

Hepatitis C infection among pregnant women in central Poland: Significance of epidemiological anamnesis and impact of screening tests to detect infection

Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2019-03, Vol.28 (3), p.313-318

2019

Volltextzugriff (PDF)

Pegylated interferon and ribavirin gone but not forgotten in the era of direct-acting antivirals

Minerva Pediatrics, 2022-02, Vol.74 (1), p.23

2022

Volltextzugriff (PDF)

Comparison of the prevalence of risk factors for Toxoplasma Gondii infection among pregnant women in rural and urban areas in Poland

Przegląd epidemiologiczny, 2023, Vol.77 (3), p.291-301

2023

Volltextzugriff (PDF)

On a straight path to HCV elimination in children – new prospects for hepatitis C treatment in Poland

Przegląd epidemiologiczny, 2020, Vol.74 (4), p.662-666

2020

Volltextzugriff (PDF)

Clinical usefulness of new noninvasive serum biomarkers for the assessment of liver fibrosis and steatosis in children with chronic hepatitis C

Clinical and Experimental Hepatology, 2017-12, Vol.4 (4), p.198-202

2017

Volltextzugriff (PDF)

Non-invasive evaluation of the liver disease severity in children with chronic viral hepatitis using FibroTest and ActiTest – comparison with histopathological assessment

Clinical and Experimental Hepatology, 2017-12, Vol.4 (4), p.187-193

2017

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(40)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of treatment with sofosbuvir/velpatasvir in patients aged 6–18 years with chronic hepatitis C—Results of the PANDAA‐PED study

Health‐related quality of life in patients aged 6–18 years with chronic hepatitis C treated with sofosbuvir/velpatasvir

Correct Implementation of Screening Testing Toward Congenital Infections During Pregnancy Reduces the Risk of Abnormal Fetal Ultrasound

Liver Fibrosis Evaluated With Transient Elastography in 35 Children With Chronic Hepatitis C Virus Infection

Real-Life Experience with Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Virus Infection with Genotypes 1 and 4 in Children Aged 12 to 17 Years—Results of the POLAC Project

Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C

Analysis of Preventable Risk Factors for Toxoplasma gondii Infection in Pregnant Women: Case-Control Study

THU-403 Liver fibrosis and steatosis in children after effective treatment of chronic hepatitis C using direct acting antivirals

THU-387 Safety and efficacy of two pangenotypic direct acting antivirals (sofosbuvir/velpatasvir and glecaprevir/pibrentasvir) for the treatment of hepatitis C in children

The Influence of Treatment With Sofosbuvir/Velpatasvir on Children’s Growth—Results of the PANDAA-PED Study

Is liver biopsy still needed in children with chronic viral hepatitis?

Testing for HIV increases the odds of correct fetal ultrasound result

Progress and Barriers Towards Elimination of Chronic Hepatitis C in Children

Health‐related quality of life in patients aged 6–18years with chronic hepatitis C treated with sofosbuvir/velpatasvir

Liver steatosis in children with chronic hepatitis B and C: Prevalence, predictors, and impact on disease progression

Efficacy and safety of treatment with sofosbuvir/velpatasvir in patients aged 6–18years with chronic hepatitis C—Results of the PANDAA‐PED study

Pruritic, Bizarre Tracks- A Vacation Souvenir

The micro-elimination approach - a new way of tackling hepatitis C in paediatric population

The influence of hepatitis B and C virus coinfection on liver histopathology in children

Hepatitis C infection among pregnant women in central Poland: Significance of epidemiological anamnesis and impact of screening tests to detect infection

Pegylated interferon and ribavirin gone but not forgotten in the era of direct-acting antivirals

Comparison of the prevalence of risk factors for Toxoplasma Gondii infection among pregnant women in rural and urban areas in Poland

On a straight path to HCV elimination in children – new prospects for hepatitis C treatment in Poland

Clinical usefulness of new noninvasive serum biomarkers for the assessment of liver fibrosis and steatosis in children with chronic hepatitis C

Non-invasive evaluation of the liver disease severity in children with chronic viral hepatitis using FibroTest and ActiTest – comparison with histopathological assessment

Suchergebnisse filtern